Global Med Continues to See Strong Sales Contributions From Channel Partners
2005年9月12日 - 11:01PM
PRニュース・ワイアー (英語)
Wyndgate Announces Over $4 Million in Channel Partner Sales DENVER,
Sept. 12 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a
division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN
BOARD: GLOB) ("Global Med"), announced today the highest demand yet
for its blood bank management software systems. Included in this
growth is the marked success of the Company's channel partners,
contributing over $4 million in sales to date for 2005 alone.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
In response to the success of its channel partners, Michael I.
Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc.
stated, "We greatly value the relationships we have with our
channel partners and their customers. One of Wyndgate's major
focuses has been to cultivate those relationships and we are
pleased to see our channel partners experiencing such high demand
for our product." Dr. Ruxin added, "We look forward to continuing
the work with our channel partners to bring Wyndgate's blood
banking solutions to new customers, and we anticipate that our
strong double-digit growth will continue." Thomas F. Marcinek,
Global Med's President and COO, said, "Wyndgate is in a period of
rapid growth and our channel partners' sales have become a major
contributor to that growth. Their escalating sales are an excellent
complement to Wyndgate's direct sales and marketing achievements,
and we are delighted to see our partners benefiting as well." Mr.
Marcinek went on to say, "Through Service 360(TM), we are committed
to continued delivery of quality products, services, and customer
satisfaction that create increasing demand for our products, thus
providing increased value for both our customers and channel
partners." About Global Med Technologies, Inc. Global Med
Technologies, Inc. is an international e-Health, medical
information technology company, providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Current clients of Wyndgate's
products and services manage more than 3 million units of blood, or
over 22% of the U.S. blood supply, each year. Wyndgate's products
are also being implemented in Canada, the Caribbean and sub-Sahara
Africa. Together, the SafeTrace Tx advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
+1-303-238-2000; or John Nesbett or Jordan Silverstein of The
Investor Relations Group, +1-212-825-3210, for Global Med
Technologies Web site: http://www.wyndgate.com/ Web site:
http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/
Copyright